Australia: Regeneron Pharmaceuticals, Sanofi Biotechnology Receive Patent for 'Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist'

  • Meagan P. O'Brien

Press/Media

Period31 May 2024

Media coverage

1

Media coverage

  • TitleAustralia: Regeneron Pharmaceuticals, Sanofi Biotechnology Receive Patent for 'Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date31/05/24
    PersonsMeagan P. O'Brien
View all 1
View less